Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells

Endocrinology. 1995 May;136(5):2345-8. doi: 10.1210/endo.136.5.7720683.

Abstract

In [3H]serine-labelled granulosa cells treatment with TNF alpha (10 ng/ml) resulted in a transient decrease in cellular [3H]sphingomyelin and generation of [3H]ceramide that remained elevated 60 min later. In cells labelled with [methyl-14C]choline, TNF alpha induced a similar reduction in [14C]sphingomyelin content that was accompanied by a sustained elevation in [14C]phosphorylcholine levels. In FSH-primed cells, TNF alpha inhibited P450-AROM activity in a dose-dependent manner, an effect that was also observed in cells treated with bacterial sphingomyelinase (SMase 0.003-0.3 U/ml) or increasing concentrations (0.1-10 microM) of N-acetylsphingosine (C2-cer) a membrane-permeable analogue of ceramide. These results support the notion that sphingomyelin degradation to a bioeffector molecule ceramide, may be an early event involved in TNF alpha-induced signal transduction in granulosa cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aromatase / metabolism*
  • Cells, Cultured
  • Ceramides / metabolism*
  • Ceramides / pharmacology*
  • Choline / metabolism
  • Female
  • Follicle Stimulating Hormone / pharmacology*
  • Granulosa Cells / drug effects
  • Granulosa Cells / metabolism*
  • Kinetics
  • Phosphorylcholine / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Serine / metabolism
  • Sphingomyelins / metabolism*
  • Tritium
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Ceramides
  • Sphingomyelins
  • Tumor Necrosis Factor-alpha
  • Tritium
  • Phosphorylcholine
  • Serine
  • Follicle Stimulating Hormone
  • Aromatase
  • Choline